TY - GEN
T1 - Nuclear membrane protein emerin
T2 - Roles in gene regulation, actin dynamics and human disease
AU - Wilson, Katherine L.
AU - Holaska, James M.
AU - De Oca, Rocio Montes
AU - Tifft, Kathryn
AU - Zastrow, Michael
AU - Segura-Totten, Miriam
AU - Mansharamani, Malini
AU - Bengtsson, Luiza
PY - 2005
Y1 - 2005
N2 - Loss of emerin, a nuclear membrane protein, causes Emery-Dreifuss muscular dystrophy (EDMD), characterized by muscle weakening, contractures of major tendons and potentially lethal cardiac conduction system defects. Emerin has a LEM-domain and therefore binds barrier-to-autointegration factor (BAF), a conserved chromatin protein essential for cell division. BAF recruits emerin to chromatin and regulates higher-order chromatin structure during nuclear assembly. Emerin also binds filaments formed by A-type lamins, mutations in which also cause EDMD. Other partners for emerin include nesprin-1α and transcriptional regulators such as germ cell-less (GCL). The binding affinities of these partners range from 4 nM (nesprin-1α) to 200 nM (BAF), and are physiologically significant. Biochemical studies therefore provide a valid means to predict the properties of emerin-lamin complexes in vivo. Emerin and lamin A together form stable complexes with either BAF or GCL in vitro. BAF, however, competes with GCL for binding to emerin in vitro. These and additional partners, notably actin and nuclear myosin I, suggest disease-relevant roles for emerin in gene regulation and the mechanical integrity of the nucleus.
AB - Loss of emerin, a nuclear membrane protein, causes Emery-Dreifuss muscular dystrophy (EDMD), characterized by muscle weakening, contractures of major tendons and potentially lethal cardiac conduction system defects. Emerin has a LEM-domain and therefore binds barrier-to-autointegration factor (BAF), a conserved chromatin protein essential for cell division. BAF recruits emerin to chromatin and regulates higher-order chromatin structure during nuclear assembly. Emerin also binds filaments formed by A-type lamins, mutations in which also cause EDMD. Other partners for emerin include nesprin-1α and transcriptional regulators such as germ cell-less (GCL). The binding affinities of these partners range from 4 nM (nesprin-1α) to 200 nM (BAF), and are physiologically significant. Biochemical studies therefore provide a valid means to predict the properties of emerin-lamin complexes in vivo. Emerin and lamin A together form stable complexes with either BAF or GCL in vitro. BAF, however, competes with GCL for binding to emerin in vitro. These and additional partners, notably actin and nuclear myosin I, suggest disease-relevant roles for emerin in gene regulation and the mechanical integrity of the nucleus.
UR - http://www.scopus.com/inward/record.url?scp=16244391076&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=16244391076&partnerID=8YFLogxK
M3 - Conference contribution
C2 - 15773747
AN - SCOPUS:16244391076
SN - 9780470093733
T3 - Novartis Foundation Symposium
SP - 51
EP - 58
BT - Nuclear Organization in Development and Disease
ER -